Literature DB >> 29487492

Chronic Intestinal Pseudo-obstruction.

Khalil El-Chammas1, Manu R Sood2,3.   

Abstract

Chronic intestinal pseudo-obstruction (CIP) is defined by either continuous or intermittent symptoms of bowel obstruction in the absence of fixed lumen excluding lesion. CIP includes a heterogeneous group of disorders which result either from diseases affecting the enteric neurons and smooth muscle lining or those involving the autonomic innervation of the bowel. Symptoms associated with CIP are nonspecific, which can sometimes contribute to the delay in recognizing the condition and making the correct diagnosis. The diagnostic workup should include imaging and manometry studies and, occasionally, full-thickness bowel biopsies for histopathological examination may be required. Multidisciplinary team approach for the management of these patients is recommended, and the team members should include a gastroenterologist, surgeon, chronic pain specialist, clinical nutritionist, and a psychologist. The treatment goals should include optimizing the nutritional status and preventing or delaying the development of intestinal failure. The majority of the patients require enteral or parenteral nutrition support, and chronic pain is a common and distressing symptom. Small bowel transplantation may be required if patients develop liver complications due to parenteral nutrition, have difficult central line access, or have poor quality of life and worsening pain despite aggressive medical management.

Entities:  

Keywords:  antroduodenal manometry; bowel motility; chronic intestinal pseudo-obstruction

Year:  2018        PMID: 29487492      PMCID: PMC5825855          DOI: 10.1055/s-0037-1609024

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  55 in total

1.  Histological phenotypes of enteric smooth muscle disease causing functional intestinal obstruction in childhood.

Authors:  V V Smith; P J Milla
Journal:  Histopathology       Date:  1997-08       Impact factor: 5.087

2.  Intestinal pseudo-obstruction and acute pandysautonomia associated with Epstein-Barr virus infection.

Authors:  M Besnard; C Faure; G Fromont-Hankard; H Ansart-Pirenne; M Peuchmaur; J P Cezard; J Navarro
Journal:  Am J Gastroenterol       Date:  2000-01       Impact factor: 10.864

Review 3.  Chronic intestinal pseudo-obstruction due to lymphocytic leiomyositis: is there a place for immunomodulatory therapy?

Authors:  E Oton; V Moreira; C Redondo; A Lopez-San-Roman; J R Foruny; G Plaza; E de Vicente; Y Quijano
Journal:  Gut       Date:  2005-09       Impact factor: 23.059

4.  JC virus infects the enteric glia of patients with chronic idiopathic intestinal pseudo-obstruction.

Authors:  M Selgrad; R De Giorgio; L Fini; R F Cogliandro; S Williams; V Stanghellini; G Barbara; M Tonini; R Corinaldesi; R M Genta; R Domiati-Saad; R Meyer; A Goel; C R Boland; L Ricciardiello
Journal:  Gut       Date:  2008-07-01       Impact factor: 23.059

5.  [Casuistic of colon disorder with symptoms of Hirschsprung's disease (author's transl)].

Authors:  W Meier-Ruge
Journal:  Verh Dtsch Ges Pathol       Date:  1971

6.  Intestinal pseudoobstruction related to cytomegalovirus infection of myenteric plexus.

Authors:  E Sonsino; R Mouy; P Foucaud; J P Cezard; Y Aigrain; L Bocquet; J Navarro
Journal:  N Engl J Med       Date:  1984-07-19       Impact factor: 91.245

7.  A familial visceral myopathy.

Authors:  D L Faulk; S Anuras; G D Gardner; F A Mitros; R W Summers; J Christensen
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

8.  Management of intractable constipation with antegrade enemas in neurologically intact children.

Authors:  Nader N Youssef; Edward Barksdale Jr; Janet M Griffiths; Alejandro F Flores; Carlo Di Lorenzo
Journal:  J Pediatr Gastroenterol Nutr       Date:  2002-04       Impact factor: 2.839

9.  Connective tissue in gut development: a key player in motility and in intestinal desmosis.

Authors:  Sonja Bruhin-Feichter; William Meier-Ruge; Giuseppe Martucciello; Elisabeth Bruder
Journal:  Eur J Pediatr Surg       Date:  2012-08-17       Impact factor: 2.191

10.  Effect of erythromycin on antroduodenal motility in children with chronic functional gastrointestinal symptoms.

Authors:  C Di Lorenzo; A F Flores; T Tomomasa; P E Hyman
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

View more
  7 in total

1.  Dlx1/2 mice have abnormal enteric nervous system function.

Authors:  Christina M Wright; James P Garifallou; Sabine Schneider; Heather L Mentch; Deepika R Kothakapa; Beth A Maguire; Robert O Heuckeroth
Journal:  JCI Insight       Date:  2020-02-27

Review 2.  Smooth muscle motility disorder phenotypes: A systematic review of cases associated with seven pathogenic genes (ACTG2, MYH11, FLNA, MYLK, RAD21, MYL9 and LMOD1).

Authors:  Ninon Fournier; Alexandre Fabre
Journal:  Intractable Rare Dis Res       Date:  2022-08

3.  Challenges in management and prognosis of pediatric intestinal pseudo-obstruction.

Authors:  Özlem Boybeyi Türer; Tutku Soyer; Hasan Özen; Umut Ece Arslan; İbrahim Karnak; Feridun Cahit Tanyel
Journal:  Turk J Gastroenterol       Date:  2020-08       Impact factor: 1.852

Review 4.  Latest developments in chronic intestinal pseudo-obstruction.

Authors:  Chang-Zhen Zhu; Hong-Wei Zhao; Hong-Wei Lin; Feng Wang; Yuan-Xin Li
Journal:  World J Clin Cases       Date:  2020-12-06       Impact factor: 1.337

5.  Rare case of visceral myopathy.

Authors:  Niloofar Sherazi Dreyer; Lina Pankratjevaite; Dainius Janciauskas; Zilvinas Saladzinskas
Journal:  J Surg Case Rep       Date:  2021-12-20

Review 6.  Paediatric intestinal pseudo-obstruction: a scoping review.

Authors:  Susan Nham; Alexander T M Nguyen; Andrew J A Holland
Journal:  Eur J Pediatr       Date:  2022-04-28       Impact factor: 3.860

7.  Clinical Outcomes of Pediatric Chronic Intestinal Pseudo-Obstruction.

Authors:  Dayoung Ko; Hee-Beom Yang; Joong Youn; Hyun-Young Kim
Journal:  J Clin Med       Date:  2021-05-28       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.